Nitin Kumar², Abhishek Bisai², Deborah Yukti Tandi¹, Vinita Singh¹, Harish Sharma¹ and Gyanesh Kumar Sahu¹*

¹Rungta Institute of Pharmaceutical Sciences and Research, Kohka, Kurud, Bhilai, India
²Rungta Institute of Pharmaceutical Sciences, Kohka, Kurud, Bhilai, India

*Corresponding Author: Gyanesh Kumar Sahu, Dean and Professor, Rungta Institute of Pharmaceutical Sciences and Research, Kohka, Kurud, Bhilai, India.

Received: April 23, 2024; Published: May 19, 2024

Abstract

Dandruff is a common disorder caused by Pityrosporum yeast which affects the scalp condition. Dandruff cannot be eradicated completely but can only be managed and controlled effectively. Preparation of Herbal shampoo using the extract of Amla powder, Hibiscus (leaf), Bhringraj, Reetha, Neem, Shikakai, and Aloe gel, etc in different quantities. Evaluation of herbal shampoo conducted with Organoleptic and physical-chemical characteristics. These shampoos leverage natural extracts to deliver essential oils and nutrients to the hair follicles, stimulating the formation of new and robust while maintaining a dandruff-free scalp. It showed cleansing and detergency, low surface tension, good foam, stability, and anti-dandruff properties. The pH of herbal shampoo was found to be around 6.4 which is good for the scalp. The shampoo was quite a good product fairly producing foams. The shampoo was containing subjected to evaluation parameters such as visual inspection, pH, viscosity, percentage of solids, soil distribution, surface tension, foamability foaming stability. The primary objective of this research was to remove the detrimental synthetic component from the anti-dandruff shampoo formulation and substitute it with a secure natural ingredient.

Keywords: Herbal Shampoo; Dandruff-free; Natural Ingredient

References

1. Bruschi ML. “Strategies to Modify the Drug Release from Pharmaceutical Systems”. Woodhead Publishing; Sawston, UK: (2015).
2. Keraliya RA., et al. “Osmotic drug delivery system as a part of modified release dosage form”. International Scholarly Research Notices 2012 (2012): 528079.
3. Siddique W., et al. “The Development of Eletriptan Hydrobromide Immediate Release Buccal Films Using Central Composite Rotatable Design: An In Vivo and In Vitro Approach”. Polymers 14 (2022): 3981.
4. Farooqi S., et al. “Quality by Design (QbD)-Based Numerical and Graphical Optimization Technique for the Development of Osmotic Pump Controlled-Release Metoclopramide HCl Tablets”. Drug Design, Development and Therapy 14 (2020): 5217.
5. Sahoo CK., et al. “Evaluation of controlled porosity osmotic pump tablets: A Review”. Research Journal of Pharmacy and Technology 8 (2015): 1340.
6. Sharma A., et al. “A review on osmotically controlled drug delivery systems”. Asian Journal of Pharmaceutical Research and Development 6 (2018): 101-109.
7. Santus G and Baker RW. “Osmotic drug delivery: A review of the patent literature”. Journal of Control Release 35 (1993): 1-21.
8. Patel KN and Mehta TA. “A review on oral osmotically driven systems”. International Journal of Pharmacy and Pharmaceutical Sciences 5 (2013): 1005-1013.
9. Prajapati HM., et al. “A review on recent innovation in osmotically”.
10. Babu A and Ratna PRV. “Controlled-porosity osmotic pump tablets—An overview”. Asian Journal of Pharmaceutical Research Health Care 2 (2010): 1.
11. Verma RK and Garg SJ. “Development and evaluation of osmotically controlled oral drug delivery system of glipizide”. European Journal of Pharmaceutics and Biopharmaceutics 57 (2004): 513-525.
12. Jerzewski RL and Chien YW. “Treatise on Controlled Drug Delivery”. CRC Press; Boca Raton, FL, USA: (2017): 225-253.
13. Banerjee A., et al. “Controlled porosity solubility modulated osmotic pump tablets of Gliclazide”. AAPS PharmSciTech 16 (2015): 554-568.
14. Makhija SN and Vavia PR. “Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine: I. Cellulose acetate as a semipermeable membrane”. Journal of Control Release 89 (2003): 5-18.
15. Markovsky E., et al. “Administration, distribution, metabolism and elimination of polymer therapeutics”. Journal of Control Release 161 (2012): 446-460.
16. Chen CM., et al. “Controlled Release Formulation for Water Insoluble Drugs in Which a Passageway is Formed In Situ”. no 5736159. U.S. Patents. 1998 April 7.
17. Farra R., et al. “First-in-Human testing of a wirelessly controlled drug delivery microchip”. Science Translational Medicine122 (2012).
18. Ouyang D., et al. “Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets”. Journal of Pharmacy and Pharmacology 57 (2005): 817-820.
19. Molnar K and Labouesse M. “The plastic cell: mechanical deformation of cells and tissues”. Open Biology2 (2012).
20. Lee A and Han B. National Science Foundation, Purdue University, Washington University at St. Louis, University of California, Irvine, University of Minnesota, He, X., Hong, S., Moon, J., Huang, X., Hossaini Nasr, S., Qian, C., Falank, C., Tasset, A., Harris, S., Farrell, M., Marinkovic, M., Reagan, M., . . . Lee, L. (2018).
21. Wakode R., et al. “Development and evaluation of push-pull based osmotic delivery system for pramipexole”. PDA Journal of Pharmaceutical Science and Technology 62 (2008): 22-31.
22. Kumaravelrajan R., et al. “Simultaneous delivery of Nifedipine and Metoprolol tartarate using sandwiched osmotic pump tablet system”. International Journal of Pharmaceutics 399 (2010): 60-70.
23. Mohanty S., et al. “Osmotic pump: A novel approach to control drug delivery”. Indo American Journal of Pharmaceutical Research 4 (2014): 2367-2373.
24. Pujara N., et al. “Osmotically Controlled Oral Drug Delivery Systems: A Novel Approach’. Invention Rapid NDDS 4 (2012): 1-8.
25. Gupta NR., et al. “A review on recent innovation in osmotically controlled drug delivery system”. Indian Journal of Pharmaceutical and Biological Research 2 (2014): 117-129.
26. Haslam JL., et al. “Controlled Porosity Osmotic Pump”. no 4880631. U.S. Patent. 1989 November 14.
27. Sahoo CK., et al. “A review on controlled porosity osmotic pump tablets and its evaluation”. Bulletin of Faculty of Pharmacy, Cairo University 53 (2015): 195-205.
28. Oakley JA., et al. “Development of a bi-functional silica monolith for electro-osmotic pumping and DNA clean-up/extraction using gel-supported reagents in a microfluidic device”. Lab on a Chip 9 (1996): 1596-1600.
29. Liu L., et al. “Monolithic osmotic tablet system for nifedipine delivery”. Journal of Control Release 67 (2000): 309-322.
30. Liu L and Che B. “Preparation of monolithic osmotic pump system by coating the indented core tablet”. European Journal of Pharmaceutics and Biopharmaceutics 64 (2006): 180-184.
31. Liu H., et al. “Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: Screening of formulation variables and in vitro investigation”. International Journal of Pharmaceutics 332 (2007): 115-124.
32. Amidon S., et al. “Colon-targeted oral drug delivery systems: Design trends and approaches”. AAPS Pharmscitech 16 (2015): 731-741.
33. Skoro‐Sajer N and Lang IM. “Extended-release oral treprostinil for the treatment of pulmonary arterial hypertension”. Expert Review of Cardiovascular Therapy12 (2014): 1391-1399.
34. Grassı G., et al. “Lercanidipine in the Management of Hypertension: an update”. Journal of Pharmacology and Pharmacotherapeutics4 (2017): 155-165.
35. DailyMed - DITROPAN XL- oxybutynin chloride tablet, extended release.
36. Altoprev (Lovastatin Extended-Release tablets): Side effects, uses, dosage, interactions, warnings. (2024).
37. US Food and Drug Administration. (n.d.). MEDICATION GUIDE TEGRETOL® and TEGRETOL®-XR (Teg-ret-ol) (carbamazepine) Tablets, Suspension, Chewable Tablets, Extended-Release Tablets.
38. Malaterre V., et al. “Oral osmotically driven systems: 30 years of development and clinical use”. European Journal of Pharmaceutics and Biopharmaceutics3 (2009): 311-323.
39. Almoshari Y. “Osmotic Pump Drug Delivery Systems—A Comprehensive Review”. Pharmaceuticals 11 (2022): 1430.
40. Mene HR., et al. “Formulation aspects in development of controlled porosity osmotic pump tablet”. Pharmaceutical and Biological Evaluations 3 (2016): 1-8.
41. Siddique W., et al. “Formulation and Evaluation of Hydroxypropyl Methylcellulose Based Topical Gel Loaded with Ganciclovir”. Latin American Journal of Pharmacy 41 (2022): 2096-2108.
42. Gupta BP., et al. “Osmotically controlled drug delivery system with associated drugs”. JPPS 13 (2010): 571-588.
43. Piyush G., et al. “A review on osmotically regulated devices”. International Journal of Life Science and Pharma Research 1 (2010): 302-312.
44. Thombre A., et al. “Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients”. Journal of Control Release 60 (1999): 333-341.
45. Khandagale PM., et al. “Osmotically Controlled Drug Delivery System-A Novel Approach”. Asian Journal of Research in Pharmaceutical Sciences 7 (2017): 68-76.
46. Xue Y., et al. “Design of a timed and controlled release osmotic pump system of atenolol”. Drug Development and Industrial Pharmacy 41 (2015): 906-915.
47. Patil P., et al. “A Review: Osmotic Drug Delivery System”. Pharma Science Monitor 9 (2018): 283-300.
48. Qiu Y and Lee P. “Developing Solid Oral Dosage Forms”. Elsevier; Amsterdam, The Netherlands: 2017. Rational design of oral modified-release drug delivery systems (2017): 519-554.
49. Khatri N., et al. “Oral osmotic drug delivery system: A review”. International Journal of Pharmaceutical Sciences and Research 7 (2016): 2302.

Citation

Citation: Gyanesh Kumar Sahu., et al. “Formulation and Evaluation of Herbal Anti-Dandruff Shampoo"Acta Scientific Pharmaceutical Sciences 8.6 (2024): 60-63.

Copyright

Copyright: © 2024 Gyanesh Kumar Sahu., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.